Source:http://linkedlifedata.com/resource/pubmed/id/19602694
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2009-7-15
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1538-3598
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
302
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
322-4
|
pubmed:dateRevised |
2009-12-18
|
pubmed:meshHeading | |
pubmed:year |
2009
|
pubmed:articleTitle |
Development of hepatitis B vaccine.
|
pubmed:affiliation |
Division of Epidemiology and Disease Control, University of Texas School of Public Health, 1200 Herman Pressler, Houston, TX 77030, USA. R.P.Beasley@uth.tmc.edu
|
pubmed:publicationType |
Journal Article,
Comment,
Historical Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|